Publication|Articles|November 18, 2026

Pharmacy Times

  • November 2026
  • Volume 92
  • Issue 11

Continuous Glucose Monitoring for Patient Empowerment and Medication Optimization

Fact checked by: Tracy Ann Politowicz

Technology empowers patients and optimizes medication use.

Recent studies are advancing the use of continuous glucose monitoring (CGM) in important ways. Evidence emerging since April 2026 supports its use in adults with type 2 diabetes (T2D) receiving basal insulin and newer medications, strengthens the case for patients who do not use insulin, and brings CGM into pharmacist-led education. Together, these findings give pharmacists more reasons to discuss how glucose patterns can inform everyday choices and medication management.1-3

Related to this article